SEC Filings

SEC Filings

Filing date	Description	Form	View
Apr 30, 2020	Annual report which provides a comprehensive overview of the company for the past year	10-K	View HTML 0001558370-20-004843.pdf 0001558370-20-004843.rtf 0001558370-20-004843.xls EX-101.INS - EX-101.INS
Apr 15, 2020	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-20-002922.pdf 0000919574-20-002922.rtf 0000919574-20-002922.xls
Apr 01, 2020	An amendment to a SC 13D filing	SC 13D/A	View HTML 0000919574-20-002685.pdf 0000919574-20-002685.rtf 0000919574-20-002685.xls
Mar 31, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-20-003452.pdf 0001558370-20-003452.rtf 0001558370-20-003452.xls
Mar 31, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-20-003464.pdf 0001558370-20-003464.rtf 0001558370-20-003464.xls
Mar 27, 2020	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-20-002611.pdf 0000919574-20-002611.rtf 0000919574-20-002611.xls
Mar 26, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-20-003196.pdf 0001558370-20-003196.rtf 0001558370-20-003196.xls
Mar 05, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-20-029733.pdf 0001104659-20-029733.rtf 0001104659-20-029733.xls
Feb 10, 2020	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001104659-20-013417.pdf 0001104659-20-013417.rtf 0001104659-20-013417.xls
Jan 31, 2020	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-20-000682.pdf 0000919574-20-000682.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE